TuHURA Biosciences (HURA) Tax Provisions (2016 - 2017)

TuHURA Biosciences' (HURA) quarterly Tax Provisions came in at -$1.9 million in Q1 2017, down 63.84% year-on-year from -$5.2 million in Q1 2016, and down 63.84% quarter-over-quarter from -$1.1 million in Q1 2016.

TuHURA Biosciences (HURA) Tax Provisions (2016 - 2017) Analysis & Trends

TuHURA Biosciences' Tax Provisions history runs 2 years deep, the most recent figure standing at -$1.9 million for Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 125,146.46
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 179.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2017 -1.87 Mn
Mar 31, 2016 -1.14 Mn